Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran

Angiology

Volumn 56, Issue 1, 2005, Pages 43-48

  Zibaeenezhad, Mohammad Javad ^a,b   Amanat, A ^a,b   Alborzi, A ^a,b   Obudi, A ^a,b  

^a Shiraz Univ of Medical Sciences ^*

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CHLAMYDIA ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIBODY TITER; ARTICLE; ATHEROGENESIS; CASE CONTROL STUDY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HUMAN; INFLAMMATION; IRAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; SEROPREVALENCE;

AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CAUSALITY; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IRAN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 12944295225     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970505600106     Document Type: Article

References (32)

1. Biasucci LM, Liuzzo G, Grillo RL, et al: Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99:855-860, 1999.
2. Haverkate F, Thompson SG, Pyke SDM, et al: Production of C-reactive and risk of coronary events in stable and unstable angina. Lancet 349:462-466, 1997.
3. Mendall MA, Patal P, Ballam L, et al: C-reactive protein and its relation to cardiovascular risk factors: A population-based cross-sectional study. BMJ 312:1061-1065, 1996.
4. Anderson JL, Carlquist JF, Muhlestein JB, et al: Evaluation of C-reactive protein and inflammatory markers, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32:35-41, 1998.
5. Becker AE, de-Boer OJ, Vander Wal AC: The role of inflammation and infection in coronary artery disease. Annu Rev Med 52:289-297, 2001.
6. Davidson M, Kuo CC, Middaugh JP, et al: Confirmed previous infection with C. pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 98:628-633, 1998.
7. Gurfinkel E: Inflammation, infection, or both in atherosclerosis: The ROXIS trial in prospective. J Infect Dis 181(suppl 3):S566-S568, 2000.
8. Kaski JC, Camm AJ: C. pneumoniae infection and coronary artery disease. J Am Coll Cardiol 34:1440-1442, 1999.
9. Leinone M: C. pneumoniae and other risk factors for atherosclerosis. J Infect Dis 181(suppl 3):S414-S416, 2000.
10. Mehta JL, Saldeen TGP, Rand K: Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31:1217-1225, 1998.
11. Muhlestein JB, Hammond EH, Carlquist JF, et al: Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 27:1555-1561, 1996.
12. Sessa R, Di Pietro M, Santino I, et al: C. pneumoniae infection and atherosclerotic coronary disease. Am Heart J 137:1116-1119, 1999.
13. Smith D, Gupta S, Kaski JC: Chronic infection and coronary heart disease (review). Int J Clin Pract 53:460-466, 1999.
14. Zhu J, Nieto FJ, Horne BD, et al: Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103:45-51, 2001.
15. Daus H, Ozbek C, Saage D, et al: Lack of evidence for a pathogenic role of C. pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 90:83-88, 1998.
16. Saikku P: Epidemiologic association of C. pneumoniae and atherosclerosis: The initial serologic observation and more. J Infect Dis 181(suppl 3):S411-S413, 2000.
17. Tavandale R, Parratt D, Pringle SD, et al: Serological markers of C. pneumoniae infection in men and women and subsequent coronary events. Eur Heart J 23:301-307, 2002.
18. Tsai CT, Kao JH, Hsu KL, et al: Relation of C. pneumoniae infection in Taiwan to angiographically demonstrated coronary artery disease and to the presence of acute myocardial infarction of unstable angina pectoris. Am J Cardiol 88:960-963, 2001.
19. Saikko P, Linonen M, Tenkanen L, et al: Chronic C. pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 116:273-278, 1992.
20. Thom DH, Grayston JT, Siscovick DS, et al: Association of prior infection with C. pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268:68-72, 1992.
21. Shimada K, Daida H, Molcumo H, et al: Association of seropositivity for antibody to Chlamydia-specific lipopolysaccharide and coronary artery disease in Japanese men. Jpn Circ J 65:182-187, 2001.
22. Thom DH, Wang SP, Grayston T, et al: C. pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb Vasc Biol 11:547-551, 1991.
23. Ridker PM, Hennekens CH, Buring JE, et al: Baseline IgG antibody titers to C. pneumoniae, H. pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 131:573-577, 1999.
24. Wald NJ, Law MR, Morris JK, et al: C. pneumoniae infection and mortality from ischemic heart disease: Large prospective study. BMJ 321:204-207, 2000.
25. Maas M, Bartales C, Engel PM, et al: Endovascular presence of viable C. pneumoniae as a common phenomenon in coronary artery disease. Am J Coll Cardiol 31:827-832, 1998.
26. Wong YK, Dawkins KD, Ward ME: Circulating C. pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 34:1435-1439, 1999.
27. Nieto FJ, Folsom AR, Sorlie PD, et al, for the atherosclerosis risk in communities (ARIC) study investigators: C. pneumoniae infection and incident coronary heart disease. The atherosclerosis risk in communities study. Am J Epidemiol 150:149-156, 1999.
28. Strachan DP, Carvington D, Mendall MA, et al: Relation of C. pneumoniae serology to mortality and incidence of ischemic heart disease over 13 years in the Caerphilly prospective heart disease study. BMJ 318:1035-1050, 1999.
29. Danesh J, Whincup P, Walker M, et al: C. pneumoniae IgG titers and coronary heart disease; prospective study and meta-analysis. BMJ 321:208-213, 2000.
30. Thomas M, Wong Y, Thomas D, et al: Relation between direct detection of C. pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 99:2733-2736, 1999.
31. Karvonen M, Tuomilehto J, Pitlcaniemi J, et al: C. pneumoniae IgG antibody prevalence in southwestern and eastern Finland in 1982 and 1987. Int J Epidemiol 23:176-184, 1994.
32. Murray LJ, O'Reilly DPJ, Ong GML, et al: C. pneumoniae antibodies are associated with an atherogenic lipid profile. Heart 81:239-244, 1999.